Lotus Pharma Stock Price, News & Analysis
Company Description
Lotus Pharma (OTC Link: LTUS) is a publicly traded shell companies company in the Financial Services sector. The company has a market capitalization of $21.2M.
LTUS stock has declined 28.0% over the past year. Shares last traded at $0.0036.
This page provides a comprehensive overview of LTUS stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.
Stock Performance
Lotus Pharma (LTUS) stock last traded at $0.0036. Over the past 12 months, the stock has lost 28.0%. At a market capitalization of $21.2M, LTUS is classified as a micro-cap stock with approximately 2.6B shares outstanding.
Latest News
Lotus Pharma has 2 recent news articles. Of the recent coverage, 1 article coincided with positive price movement and 1 with negative movement. View all LTUS news →
SEC Filings
Financial Highlights
Upcoming Events
Short Interest History
Short interest in Lotus Pharma (LTUS) currently stands at 17.6 thousand shares, up 11.9% from the previous reporting period, representing 0.0% of the float. Over the past 12 months, short interest has increased by 105.5%. This relatively low short interest suggests limited bearish sentiment.
Days to Cover History
Days to cover for Lotus Pharma (LTUS) currently stands at 1.0 days, down 99.9% from the previous period. This low days-to-cover ratio indicates high liquidity, allowing short sellers to quickly exit positions if needed. The ratio has shown significant volatility over the period, ranging from 1.0 to 1000.0 days.
LTUS Company Profile & Sector Positioning
Lotus Pharma (LTUS) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the OTC Link.
Investors comparing LTUS often look at related companies in the same sector, including Elbit Imaging (EMITF), Annabidiol (ACBD), Breeze Holdings (BRZH), Goldenstone Acquisition Limited (GDST), and Trex Acquisition Corp (TRXA). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate LTUS's relative position within its industry.